Product Information
ORPHENADRINE ER 100 MG TABLET is a generic product labeled by Sandoz Inc., priced at $0.4750 per EA under NDC 00185002201. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
100 mg/1
Manufacturer
Sandoz Inc.NDC
00185002201
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ORPHENADRINE CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA040327On Market Since
2/15/2000
Pharmacological Classes
Price Statistics
The NADAC for ORPHENADRINE ER 100 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 27.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4750 per EA |
|---|---|
| All-time high | $0.5364 (Dec 14, 2022) |
| All-time low | $0.2632 (Jan 22, 2020) |
| 52-week high | $0.4750 |
| 52-week low | $0.4280 |
| Median price | $0.3886 |
| Average price | $0.3861 |
| Largest weekly change | +70.2% (Aug 19, 2020) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Orphenadrine Citrate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ORPHENADRINE ER 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ORPHENADRINE ER 100 MG TABLET, manufactured by Sandoz Inc., is $0.4750 per EA (NDC 00185002201), effective Jun 24, 2026.
How has the price of ORPHENADRINE ER 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for ORPHENADRINE ER 100 MG TABLET has risen 27.6%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ORPHENADRINE ER 100 MG TABLET?
Since Nov 28, 2013, the NADAC for ORPHENADRINE ER 100 MG TABLET has ranged from a low of $0.2632 (Jan 22, 2020) to a high of $0.5364 (Dec 14, 2022), with a median of $0.3886 per EA.
Are there cheaper alternatives to ORPHENADRINE ER 100 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ORPHENADRINE ER 100 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ORPHENADRINE ER 100 MG TABLET?
ORPHENADRINE ER 100 MG TABLET (NDC 00185002201) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification